Skip to main content

Assoc. Prof. Cengiz Dibekoğlu, MD

General Surgeon · Laparoscopic · Robotic · Oncologic Surgery

Detailed chapter

Liver Disease — Viral Hepatitis

Hepatitis B, C, and chronic risk

Viral hepatitis—especially B and C—can cause acute or chronic liver inflammation. Chronic disease raises cirrhosis and HCC risk. Hepatitis A is usually self-limited; hepatitis B has an effective vaccine; modern oral antivirals cure most hepatitis C.

Viral hepatitis · educational illustration

Educational schematic. Some structures may be simplified or emphasized for clarity; not an exact anatomical depiction.

© Cengiz Dibekoğlu — illustrative; not for unauthorized use

Figure summary

This educational figure shows: Viral hepatitis.

Key points

  • Hepatitis B

    Spreads through blood and body fluids. Vaccination is central to prevention. Chronic infection may need antiviral therapy and HCC surveillance.

  • Hepatitis C

    Blood-borne transmission. Direct-acting antivirals achieve sustained virologic response in most patients. Cirrhosis still needs follow-up after cure.

  • When to worry

    Jaundice, dark urine, profound fatigue, or known exposure warrant testing. Gastroenterology or infectious disease guides chronic care.

  • Protecting contacts

    Household and sexual partners of hepatitis B should be tested and vaccinated if not immune. Hepatitis C has no vaccine—avoid blood exposure.

More chapters in this hub

Appointment / info

+90 542 725 50 70WhatsAppTumor boardBack to hub →Full Turkish chapter →

This page is for education. It is not medical advice and does not replace a visit with your physician.

Medical editor: Assoc. Prof. Cengiz Dibekoğlu, MD · Last medically reviewed: August 2026 · English patient-education chapter.

AppointmentWhatsAppMessageTumor boardRequest